Data for (Study ST003467)
(Analysis AN005700)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 |
|---|---|---|---|---|---|---|---|
| 11,12-Epoxy-(5Z,8Z,11Z)-icosatrienoic acid | 1.3679 | 1.1344 | 1.1230 | NA | 0.7382 | 0.7527 | 0.9271 |
| (+/-)13-HODE | 2.9160 | 0.6591 | 1.9721 | NA | 0.1170 | 0.3850 | 0.2492 |
| 14(S)-HDHA | 1.8887 | 1.3743 | 1.5481 | NA | 0.2162 | 0.6624 | 0.4457 |
| 5-[(1S,2R,4aR)-5-(Hydroxymethyl)-1,2,4a-trimethyl-1,2,3,4,4a,7,8,8a-octahydro-1-naphthalenyl]-3-methylpentanoic acid | 2.1245 | 1.0317 | 1.4760 | NA | 0.2948 | 0.6365 | 0.5660 |
| Bicyclo Prostaglandin E2 | 1.0114 | 1.0488 | 0.5254 | NA | 1.3741 | 0.6654 | 1.1833 |
| Cer 18:1;2O/22:0 | 1.3485 | 1.0047 | 1.6710 | NA | 0.8367 | 0.3355 | 1.1856 |
| Deoxycholic acid | 0.6262 | 0.9287 | 0.3948 | NA | 0.0460 | 3.4469 | 0.0063 |
| FA 18:2 | 2.4493 | 0.9578 | 1.5357 | NA | 0.2800 | 0.4692 | 0.4344 |
| FA 20:4 | 0.8797 | 1.2143 | 0.8354 | NA | 0.8530 | 1.0065 | 1.1718 |
| FA 20:6 | 1.2004 | 1.5315 | 1.2486 | NA | 0.4846 | 0.7020 | 0.9430 |
| LPE 16:0 | 0.9311 | 1.0020 | 1.3955 | NA | 1.0580 | 0.5839 | 1.3029 |
| LPE 36:1 | 0.6675 | 1.2014 | 0.7330 | NA | 1.0445 | 0.8469 | 1.4977 |
| LPE 38:2 | 0.8122 | 1.1166 | 0.9368 | NA | 1.0848 | 0.8008 | 1.2895 |
| LPE 38:4 | 0.6982 | 1.0175 | 0.9018 | NA | 1.0015 | 1.0451 | 1.3823 |
| LPI 18:0 | 1.1910 | 1.0577 | 1.1230 | NA | 0.8195 | 0.7330 | 1.1831 |
| LPI 20:4 | 0.7955 | 0.9909 | 0.7548 | NA | 1.0205 | 1.0215 | 1.3921 |
| PE 18:0/20:5 | 1.2238 | 0.9534 | 1.1575 | NA | 1.1230 | 0.5797 | 1.0551 |
| PE 18:1/18:2 | 1.5353 | 0.9895 | 1.5668 | NA | 0.8798 | 0.5630 | 0.6653 |
| PE 18:1/22:6 | 0.8774 | 1.0926 | 1.5954 | NA | 1.1381 | 0.7654 | 0.7717 |
| PE O-16:1/20:4 | 0.5782 | 1.2025 | 1.0754 | NA | 0.9907 | 0.8296 | 1.4817 |
| PE O-16:1/22:6 | 0.4868 | 1.2460 | 0.9883 | NA | 1.0243 | 0.8383 | 1.5472 |
| PE O-18:0/22:4 | 0.8394 | 1.2365 | 1.1846 | NA | 0.9515 | 0.8658 | 1.0193 |
| PE O-18:1/22:6 | 0.4929 | 1.2438 | 1.1685 | NA | 0.9025 | 0.8709 | 1.5409 |
| PE O-20:0/22:4 | 0.9778 | 1.1944 | 1.2580 | NA | 0.9398 | 0.8586 | 0.8672 |
| PE O-20:0/22:5 | 1.0170 | 1.0990 | 1.0444 | NA | 0.9546 | 0.8167 | 1.1206 |
| PE O 38:1 | 0.7084 | 1.3501 | 0.9595 | NA | 0.7337 | 0.7770 | 1.6014 |
| PI 16:0/18:2 | 1.3342 | 0.7614 | 0.5055 | NA | 1.3993 | 0.7439 | 1.0112 |
| PI 16:0/20:4 | 1.2192 | 0.7739 | 0.6362 | NA | 1.3530 | 0.7686 | 1.0896 |
| PI 18:0/18:2 | 1.0257 | 0.6469 | 0.5989 | NA | 1.6822 | 0.7642 | 1.1088 |
| PI 18:0/20:3 | 0.9316 | 0.4607 | 0.2671 | NA | 2.4078 | 0.4939 | 1.0967 |
| PI 18:0/20:4 | 0.7220 | 0.9849 | 0.6294 | NA | 1.2584 | 0.9788 | 1.3215 |
| PI 18:1/18:2 | 1.7814 | 0.7356 | 0.4799 | NA | 1.3888 | 0.5849 | 0.6925 |
| PI 18:1/20:4 | 1.7602 | 0.7202 | 0.4182 | NA | 1.5096 | 0.5308 | 0.6935 |
| PI 37:4 | 1.0328 | 1.0069 | 0.7095 | NA | 0.9739 | 0.9937 | 1.1839 |
| PI 38:6 | 1.0974 | 0.8170 | 0.6736 | NA | 1.2976 | 0.7510 | 1.2669 |
| PI 39:4 | 0.5572 | 1.0779 | 0.6735 | NA | 1.1866 | 1.1550 | 1.2486 |
| SL 17:0;O/15:0 | 0.9476 | 0.9476 | 1.2469 | NA | 1.1300 | 0.5445 | 1.4091 |
| SL 17:0;O/16:0;O | 1.1865 | 0.9346 | 1.1703 | NA | 1.1958 | 0.4165 | 1.2419 |
| SL 17:0;O/16:1;O | 0.8186 | 1.1406 | 1.6351 | NA | 1.0969 | 0.5666 | 1.0796 |
| SL 17:0;O/17:0;O | 1.2056 | 0.8830 | 1.1214 | NA | 1.2699 | 0.3651 | 1.2876 |
| SL 18:0;O/16:0;O | 1.4564 | 0.7369 | 1.0009 | NA | 1.3530 | 0.2168 | 1.3153 |
| ST 27:1;O;S | 1.2635 | 0.9941 | 1.6492 | NA | 0.7623 | 0.5223 | 1.1775 |
Factors:
| F1 | Sample source:Serum | Group:CLP (24h) / 12C-Serin |
| F2 | Sample source:Serum | Group:CLP (24h) / 13C-Serin |
| F3 | Sample source:Serum | Group:CLP (24h) / Vehicle |
| F4 | Sample source:Serum | Group:QC |
| F5 | Sample source:Serum | Group:Sham / 12C-Serin |
| F6 | Sample source:Serum | Group:Sham / 13C-Serin |
| F7 | Sample source:Serum | Group:Sham / Vehicle |
